Human serum albumin as the carrier to fabricate STING-activating peptide nanovaccine for antitumor immunotherapy
Tumor vaccines are emerging as one of the most promising therapeutic strategies for cancer treatment. With the advantages of low toxicity, convenient production and stable quality control, peptide vaccines have been widely used in preclinical and clinical trials involving various malignancies. Howev...
Tallennettuna:
| Päätekijät: | , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2024-04-01
|
| Sarja: | Materials Today Bio |
| Aiheet: | |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S2590006424000140 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|